tyrosine kinase inhibitor

Definitions

  • WordNet 3.6
    • n tyrosine kinase inhibitor a drug used in cases of chronic myeloid leukemia
    • ***

Usage


In news:

The second generation tyrosine kinase inhibitor nilotinib (Drug information on nilotinib Tasigna) has proven to be an effective treatment for imatinib (Drug information on imatinib) -resistant patients with chronic myeloid leukemia (CML).
Crizotinib is a receptor tyrosine kinase inhibitor that blocks cell signaling by tyrosine kinases ALK, hepatocyte growth factor receptor (HGFR, c-Met) and Recepteur d'Origine Nantais (RON).
Tyrosine kinase inhibitors (TKIs) are indicated for the treatment of a variety of malignancies due to their ability to interfere with cell communication and growth.
Perioperative Tyrosine Kinase Inhibitors for GIST: Standard.
Itch is a common side-effect of treatment with anti-EGFR antibodies and tyrosine-kinase inhibitors.
Tyrosine kinase inhibitors (TKIs) are indicated for the treatment of a variety of malignancies due to their ability to interfere with cell communication and growth.
The ABL tyrosine kinase inhibitor STI571 is a promising agent for treatment of advanced Philadelphia-chromosome-positive (Ph+) acute lymphoblastic leukaemia.
Iclusig acts by blocking mutations that develop with the current class of drugs , called tyrosine kinase inhibitors, made by pharmaceutical giants Novartis AG and Bristol-Myers Squibb Co.
The targeted therapies used to treat leukemias and lymphomas include monoclonal antibodies, tyrosine kinase inhibitors, histone deacetylase inhibitors, hypermethylation inhibitors, and proteasome inhibitors.
***